CPhI has released the findings of its 2017 India Pharma Market Report, identifying improved international repute of India but an urgent call for government support for investment in active pharmaceutical ingredient (API) facilities.
Global pharmaceutical and biopharmaceutical open access capability platform, WuXi AppTec, has published a report on immunotherapy, identifying that smaller biotech firms and early-stage companies will be the biggest driver behind therapy innovation.
During the Next Generation Dx summit 2017 in Washington, DC, Dr Neil Polwart — Novarum DX founder and BBI group head of mobile — will discuss the impact smartphones will have on the healthcare industry in the next few years.
Health science marketing and communications firm, SCORR Marketing, has released the results of its Global Trends Survey Report, which is focused on the health science industry.
A new paper from EEF is urging the government to set out clear guidance on the rules of engagement for industry sector deals ahead of the release of the Industrial Strategy White Paper, to minimise the impact of Brexit on supply chains.
Allison Gilpin, business unit manager, global serialisation and Ray Hook, manager global serialisation services, PCI Pharma Services, discuss the impact of serialisation requirements on packaging operations.
In the third episode of our series, we talk to Richard Limb who is the new head of Quality Assurance at one of the UK’s independent suppliers of both Specials and clinical trial medicines to healthcare professionals, Nova Laboratories.
Are you preparing for serialisation? Carlos Machado, SEA Vision US, explores some of the challenges and opportunities companies are facing when preparing for serialisation and outlines some steps to success for those that are yet to make a start.
With serialisation efforts in full swing connecting the dots across the full supply chain is becoming important. Here, Christophe Devins and Chuck Sailer, Adents, explain why Level 4 serialisation is uniquely positioned for data sharing.
